九洲药业(603456.SH)发布前三季度业绩，归母净利润7.48亿元，同比增长18.51%

Core Viewpoint - Jiuzhou Pharmaceutical (603456.SH) reported a revenue of 4.16 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 4.92% [1] - The net profit attributable to shareholders reached 748 million yuan, marking an 18.51% increase year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 746 million yuan, showing a year-on-year growth of 20.67% [1] Financial Performance - Revenue for the first three quarters: 4.16 billion yuan, up 4.92% year-on-year [1] - Net profit attributable to shareholders: 748 million yuan, up 18.51% year-on-year [1] - Net profit after deducting non-recurring gains and losses: 746 million yuan, up 20.67% year-on-year [1]